It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The use of endobiliary radiofrequency ablation (RFA) to generate a benign biliary stricture (BBS) model has a significant reproducibility problem. The aims of this animal study were to create an optimal BBS model using endobiliary RFA and determine the best way to develop it. The first step was performed on the common bile duct (CBD) of 10 miniature pigs using endoscopic RFA with a target temperature-controlled mode (80 ℃, 7 W for 90 s). The second step was performed on the CBD of five miniature pigs to understand more about the time-dependent changes in BBS development and the causes of adverse events. Using the conditions and techniques identified in the previous steps, the third step was conducted to create an optimal BBS model in 12 miniature pigs. In the first trial, four out of 10 animals died (40%) after the procedure due to cholangitis-induced sepsis. Based on this, biliary obstruction was prevented in further steps by placing a biliary plastic stent after RFA application. Histologic examinations over time showed that a severe abscess developed at the RFA application site on the fifth day, followed by fibrosis on the tenth day, and completion on the twentieth day. In the third trial, 11 animals survived (91.7%), the average BBS fibrotic wall thickness was 1107.9 µm (763.1–1864.6 µm), and the degree of upstream biliary dilation was 14.4 mm (11.05–20.7 mm). In conclusion, endobiliary RFA combined with a biliary plastic stent resulted in a safe and reproducible BBS animal model.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 CHA Bundang Medical Center, CHA University School of Medicine, Digestive Disease Center, Seongnam, Republic of Korea (GRID:grid.452398.1) (ISNI:0000 0004 0570 1076)
2 Gangnam Severance Hospital, Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Republic of Korea (GRID:grid.459553.b) (ISNI:0000 0004 0647 8021)
3 Inha University School of Medicine, Inha University Hospital, Division of Gastroenterology, Department of Internal Medicine, Incheon, Republic of Korea (GRID:grid.459553.b)
4 CHA Bundang Medical Center, CHA University School of Medicine, Department of Pathology, Seongnam, Republic of Korea (GRID:grid.452398.1) (ISNI:0000 0004 0570 1076)
5 SoonChunHyang Cheonan Hospital, Soonchunhyang University College of Medicine, Department of Internal Medicine, Cheonan, Republic of Korea (GRID:grid.412674.2) (ISNI:0000 0004 1773 6524)
6 Gangnam Severance Hospital, Yonsei University College of Medicine, Department of Pathology, Seoul, Republic of Korea (GRID:grid.459553.b) (ISNI:0000 0004 0647 8021)